Cell Stem Cell
Tracked across 7 events · 45 articles · First seen Jul 02, 2026 · Last active Sep 21, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Business
Regenerative Medical Technology Group, Inc. (RMTG), through its Cellgenic division, announced on September 8, 2026, that it has commenced local commercial arrangements in Colombia, including establishing local representation and developing relationships with physicians and medical…
Impact: Wholly owned subsidiary through which RMTG operates; benefits from expansion.
Sep 08, 2026 · 6 articles
Business
Regenerative Medical Technology Group, Inc. (OTCID:RMTG) announced on September 17, 2026 the launch, through its ISSCA division, of a new Integrative Fellowship in Point-of-Care Regenerative Medicine. The fellowship is described as ISSCA's most comprehensive credential…
Impact: As the wholly owned subsidiary through which RMTG operates and the parent of ISSCA, it is the operating vehicle for the new fellowship and the broader physician-education network spanning more than 30 countries.
Sep 17, 2026 · 6 articles
Business
Regenerative Medical Technology Group announced that its physician-education platform, the International Society for Stem Cell Application, will host the ISSCA 125 Global Summit from September 25-27, 2026 at the JW Marriott Cancun Resort and Spa…
Impact: As the wholly owned subsidiary operating the ISSCA physician-education platform, it is the vehicle through which the summit is conducted and its ecosystem is showcased.
Sep 21, 2026 · 6 articles
Business
Impact: Wholly owned subsidiary of RMTG, through which the expansion is conducted.
Jul 23, 2026 · 6 articles
Business
Impact: As RMTG's wholly owned subsidiary, Cell Stem Cell is the operational driver behind the growth discussed, benefiting from increased visibility.
Aug 05, 2026 · 9 articles
Tech
Impact: Cell Stem Cell is the journal that published the research, providing a platform for the scientific community to access these findings.
Jul 02, 2026 · 6 articles
Business
Impact: Cell Stem Cell is the wholly owned subsidiary through which RMTG operates. The website launch indirectly supports its parent's investor relations but has no direct operational impact.
Aug 26, 2026 · 6 articles
Regenerative Medical Technology Group
subsidiary
↔
Cell Stem Cell
Cell Stem Cell is a wholly owned operating subsidiary of Regenerative Medical Te
David Christensen
executive
↔
Cell Stem Cell
David Christensen is the CEO and President of Regenerative Medical Technology Gr
Regenerative Medical Technology Group
parent
↔
Cell Stem Cell
Regenerative Medical Technology Group wholly owns Cell Stem Cell, which function
ERGEN INTELLIGENCE
Track Cell Stem Cell live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard